GlassScriptPhysician profile
Raman Baweja
NPI 1881824993
$11,246.60
in general payments reported to CMS, 2019-2025
6 companies · $199 in 2025
The $199 reported for 2025 was more than what a typical Child & Adolescent Psychiatry provider received nationally (typical 2025 total: $132).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $85.73 · 2023: $32.76 · 2024: $11K · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,395 · Travel and Lodging: $2,749 · Food and Beverage: $1,016.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,395.00 |
| Travel and Lodging | $2,749.45 |
| Food and Beverage | $1,016.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $10,888.72 | 2022-2024 | |
| Tris Pharma INC | $113.07 | 2023-2025 | Onyda Xr, Dyanavel Xr |
| Collegium Pharmaceutical, INC. | $112.92 | 2025 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $100.81 | 2024-2025 | Qelbree |
| Sage Therapeutics, LLC | $31.08 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raman Baweja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.